Dermal Filler Types: A Guide to Hyaluronic Acid, CaHA, and PLLA Formulations

Dermal fillers are injectable medical devices used to restore or enhance soft-tissue volume, improve facial contours, and reduce the appearance of selected wrinkles and folds. Their development has progressed substantially since the earliest injectable augmentation procedures in the late 19th century.

Paraffin was among the earliest materials used, but complications such as migration, embolization, and granuloma formation ultimately led to its abandonment. Bovine collagen became the first injectable filler approved by the U.S. Food and Drug Administration (FDA) for cosmetic use in 1981. This was followed by the development of newer materials with different mechanisms, tissue interactions, durability, and safety profiles.

In this article, we will look into the dermal filler types that encompass several biomaterials. This includes hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA). Selection depends not only on the filler material but also on its formulation, rheological characteristics, injection depth, anatomical site, treatment objective, and the patient’s individual anatomy.

Types of Dermal Fillers

Dermal fillers can be classified according to their composition and how long they persist in tissue. Broadly, they include temporary or absorbable materials, such as HA, CaHA, and PLLA, as well as longer-lasting or permanent materials such as PMMA. Different formulations within the same material class can also have substantially different physical properties, including viscosity, elasticity, cohesivity, particle characteristics, and resistance to degradation.

These properties influence how a product behaves after injection and where it may be appropriate to use it. For example, a softer HA formulation may be selected for superficial correction, while a more structurally supportive formulation may be appropriate for deeper volume restoration or contouring.

Consequently, purchasing decisions should be based on the specific product, regulatory status, intended indication, and professional requirements rather than simply the filler category; professionals researching how to buy dermal fillers online should verify product authenticity, authorized distribution, labeling, and applicable regulatory requirements before use.

The term “dermal filler” therefore does not describe a single type of product. It represents a broad group of injectable materials with different mechanisms, durations, and clinical applications.

Hyaluronic Acid Fillers: Most Known Among Dermal Filler Types

Hyaluronic acid is one of the most widely used materials in modern dermal filler therapy. It is a naturally occurring polysaccharide found throughout the body, including the skin and connective tissues. In injectable fillers, HA is typically formulated as a gel, and many products use chemical cross-linking to increase resistance to degradation and modify the material’s physical characteristics.

HA fillers are particularly versatile because manufacturers can modify their concentration, degree of cross-linking, particle structure, and rheological properties. These differences allow clinicians to select formulations according to the desired degree of projection, tissue integration, flexibility, and longevity.

Depending on the specific formulation and indication, HA fillers may be used for areas such as the lips, cheeks, chin, nasolabial folds, and other facial contours. FDA-approved uses vary by individual product, so an indication for one HA filler should not automatically be assumed to apply to every product in the category.

Another important characteristic of HA fillers is that they can generally be degraded with hyaluronidase when clinically indicated. This property can be particularly important when managing certain complications or correcting unwanted HA accumulation. However, hyaluronidase treatment should be performed by appropriately trained clinicians because the underlying complication and its severity must first be assessed.

HA is also associated with water-binding properties, contributing to the volumizing and tissue-hydrating characteristics of many formulations. The duration of clinical effect varies according to the specific product, injection site, treatment technique, and individual patient factors rather than following a single fixed timeframe. The FDA notes that approved HA filler effects generally last approximately 6–12 months, although individual products and indications can differ.

From a historical perspective, modern HA fillers also helped address some limitations associated with earlier collagen products. The FDA-approved filler landscape now includes numerous HA formulations, while older bovine collagen products have become far less prominent in aesthetic practice.

Calcium Hydroxylapatite

Calcium hydroxylapatite is a biodegradable, biocompatible mineral material that resembles the inorganic mineral component naturally found in human bone and teeth. In dermal fillers, CaHA particles are suspended in a gel carrier, creating a formulation that can provide both immediate structural support and longer-term tissue effects.

Compared with many softer HA formulations, CaHA can provide greater structural support and is therefore commonly considered for deeper tissue correction and contouring. Depending on the specific product and jurisdiction, applications can include correction of facial folds, volume restoration, contour enhancement, and hand rejuvenation.

CaHA is not generally considered the first choice for every superficial line or highly mobile anatomical area. Product characteristics and injection technique are important because inappropriate placement can contribute to palpable or visible irregularities. Published clinical literature has reported nodules among the recognized adverse events associated with CaHA, although the overall safety profile is generally favorable when appropriately selected and administered.

Among the wide selection of dermal filler types, the FDA describes CaHA as an absorbable material whose effects generally last approximately 18 months. As with other fillers, actual longevity varies according to the formulation, anatomical site, injected volume, patient characteristics, and other clinical factors.

An important distinction is that CaHA should not be confused with a permanent implant. Although its effects can persist considerably longer than those of some HA formulations, the material is biodegradable and is eventually processed by the body.

Poly-L-lactic Acid

Poly-L-lactic acid is a biodegradable synthetic polymer used in injectable aesthetic treatments to address volume loss. Unlike a conventional volumizing HA gel, PLLA is primarily considered a biostimulatory filler because its clinical effect develops progressively as the material stimulates collagen production.

PLLA is commonly used when gradual restoration of facial volume is desired, particularly in patients with diffuse volume loss associated with aging or other conditions. Treatment generally involves a series of sessions rather than relying on a single injection to produce the final result.

Because the effect develops progressively, PLLA can produce a less immediate change than a conventional HA filler. The FDA describes PLLA as a long-lasting material whose effects generally become increasingly apparent over several weeks and may last up to two years.

The gradual nature of PLLA treatment can be advantageous when the treatment objective is progressive restoration rather than immediate. However, patient selection, reconstitution, injection technique, treatment spacing, and appropriate product preparation are important considerations because PLLA has a different handling and clinical profile from HA fillers.

PLLA should also not be regarded as interchangeable with CaHA. Both can have biostimulatory effects, but they differ in composition, physical properties, treatment protocols, and clinical behavior. The choice between them should therefore be based on the patient’s anatomy, treatment objectives, product-specific evidence, and the clinician’s expertise.

What’s The Best Dermal Filler Type?

Among the many dermal filler types, here is no universally “best” dermal filler. The most appropriate material depends on the anatomical area being treated, the degree and type of volume loss, the desired aesthetic outcome, the properties of the specific formulation, expected duration, previous treatments, and the patient’s risk profile.

HA is often favored for its versatility and the availability of formulations with different physical properties. Its reversibility with hyaluronidase when clinically appropriate is another consideration. CaHA may be preferable when greater structural support or particular contouring characteristics are desired. Meanwhile, PLLA can be considered when gradual collagen-mediated restoration of volume is the treatment objective.

Patients and clinicians may also ask, are dermal fillers vegan? The answer depends on the individual product rather than the filler category alone. Some HA fillers are manufactured through microbial fermentation and can be considered non-animal-derived with respect to their HA component. Moreover, other formulations may historically have used animal-derived sources. CaHA and PLLA are manufactured from synthetic or mineral-based materials, but the complete formulation, manufacturing process, excipients, and packaging should be checked with the manufacturer before a product is described as vegan.

This distinction is particularly important because “non-animal-derived” and “vegan” are not necessarily interchangeable regulatory or manufacturing claims. Professionals should consult the manufacturer’s current product documentation when a patient’s treatment decision depends on the absence of animal-derived ingredients.

Regardless of material, dermal filler treatment carries potential adverse effects. Common reactions can include swelling, bruising, redness, tenderness, and palpable irregularities, while uncommon but serious complications can include infection, tissue ischemia from vascular occlusion, and visual complications. Appropriate anatomical knowledge, product selection, injection technique, and the ability to recognize and manage complications are therefore essential components of safe filler practice.

Conclusion

Dermal filler types have evolved considerably from the early injectable materials used in the 19th and early 20th centuries. Modern products offer clinicians a broad range of biomaterials and formulations designed to address different patterns of volume loss, contour deficiency, and facial aging.

Among the major contemporary categories, HA, CaHA, and PLLA each have distinct characteristics. HA offers considerable formulation versatility and can be enzymatically degraded when clinically appropriate; CaHA provides structural support and is biodegradable; and PLLA produces a gradual effect through collagen stimulation. Other materials, including PMMA, remain available for specific indications but have different persistence and safety considerations.

Rather than selecting a filler solely on the basis of popularity or longevity, clinicians should consider the patient’s anatomy, treatment objective, product-specific evidence, regulatory status, and the material’s physical and biological characteristics. Appropriate assessment and administration by trained healthcare professionals remain fundamental to achieving predictable outcomes and minimizing complications.

FAQs

1. What are the main types of dermal fillers?

The principal dermal filler types include hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate. They differ in composition, persistence, mechanism of action, and approved indications.

2. Which dermal filler lasts the longest?

Longevity varies substantially by product and treatment area, but PMMA is a non-biodegradable filler, while HA, CaHA, and PLLA are absorbable materials with effects that can persist for months to years depending on the product.

3. Can dermal fillers be removed?

HA fillers can generally be degraded with hyaluronidase when clinically appropriate, whereas non-HA materials such as CaHA and PLLA do not have an equivalent dissolving enzyme. Persistent or permanent materials require different approaches if complications or unwanted results occur.

Citations

[1] Center for Devices and Radiological Health. “FDA-Approved Dermal Fillers.” U.S. Food And Drug Administration, 9 Nov. 2020, www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers?utm_source=chatgpt.com.

[2] Kontis, Theda, and Alexander Rivkin. “The History of Injectable Facial Fillers.” Facial Plastic Surgery, vol. 25, no. 02, May 2009, pp. 067–72. https://doi.org/10.1055/s-0029-1220645.

[3] Daines, Steven M., and Edwin F. Williams. “Complications Associated With Injectable Soft-Tissue Fillers.” JAMA Facial Plastic Surgery, vol. 15, no. 3, Mar. 2013, pp. 226–31. https://doi.org/10.1001/jamafacial.2013.798.